Sandra Calvin
SVP, CHIEF ACCOUNTING OFFICER · Travere Therapeutics, Inc.
- 2024
- Sep 18, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sandra Calvin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Peter Heerma - $18.77M in TVTX purchases and sales in the last 12 months
- William E. Rote - $14.02M in TVTX purchases and sales in the last 12 months
- Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
- Christopher R. Cline - $4.64M in TVTX purchases and sales in the last 12 months
- Jula Inrig - $4.53M in TVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sandra Calvin?
Sandra Calvin is a corporate insider, tracked as SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sandra Calvin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sandra Calvin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($4.38M) across all tracked filings.
